Researchers Say Spironolactone May Be Safe For Treatment Of Alopecia In Breast Cancer Survivors

Medscape (3/26, Jancin, Subscription Publication) reports researchers found in a large retrospective study that "treatment of endocrine therapy-induced alopecia in breast cancer survivors" with spironolactone "was not associated with increased risk of recurrence of the malignancy." The findings were presented in a virtual meeting held by George Washington University's dermatology department.

Sent from my iPhone

Benjamin Hidalgo-Matlock
Skin Care Physicians of Costa Rica

Clinica Victoria en San Pedro: 4000-1054
Momentum Escazu: 2101-9574

Please excuse the shortness of this message, as it has been sent from
a mobile device.